Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrating blue: How do we make nationally determined contributions work for both blue carbon and local coastal communities?
Dencer-Brown AM, Shilland R, Friess D, Herr D, Benson L, Berry NJ, Cifuentes-Jara M, Colas P, Damayanti E, García EL, Gavaldão M, Grimsditch G, Hejnowicz AP, Howard J, Islam ST, Kennedy H, Kivugo RR, Lang'at JKS, Lovelock C, Malleson R, Macreadie PI, Andrade-Medina R, Mohamed A, Pidgeon E, Ramos J, Rosette M, Salim MM, Schoof E, Talukder B, Thomas T, Vanderklift MA, Huxham M. Dencer-Brown AM, et al. Among authors: howard j. Ambio. 2022 Sep;51(9):1978-1993. doi: 10.1007/s13280-022-01723-1. Epub 2022 May 3. Ambio. 2022. PMID: 35503201 Free PMC article.
Mangrove blue carbon stocks and dynamics are controlled by hydrogeomorphic settings and land-use change.
Sasmito SD, Sillanpää M, Hayes MA, Bachri S, Saragi-Sasmito MF, Sidik F, Hanggara BB, Mofu WY, Rumbiak VI, Hendri, Taberima S, Suhaemi, Nugroho JD, Pattiasina TF, Widagti N, Barakalla, Rahajoe JS, Hartantri H, Nikijuluw V, Jowey RN, Heatubun CD, Zu Ermgassen P, Worthington TA, Howard J, Lovelock CE, Friess DA, Hutley LB, Murdiyarso D. Sasmito SD, et al. Among authors: howard j. Glob Chang Biol. 2020 May;26(5):3028-3039. doi: 10.1111/gcb.15056. Epub 2020 Mar 24. Glob Chang Biol. 2020. PMID: 32112604 Free PMC article.
ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter, Phase 3 Study.
Zager JS, Orloff M, Ferrucci PF, Choi J, Eschelman DJ, Glazer ES, Ejaz A, Howard JH, Richtig E, Ochsenreither S, Reddy SA, Lowe MC, Beasley GM, Gesierich A, Bender A, Gschnell M, Dummer R, Rivoire M, Arance A, Fenwick SW, Sacco JJ, Haferkamp S, Weishaupt C, John J, Wheater M, Ottensmeier CH. Zager JS, et al. Among authors: howard jh. Ann Surg Oncol. 2024 May 24. doi: 10.1245/s10434-024-15421-7. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38789613 No abstract available.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00548-8. doi: 10.1016/S0140-6736(24)00548-8. Online ahead of print. Lancet. 2024. PMID: 38763154 Free article.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00549-X. doi: 10.1016/S0140-6736(24)00549-X. Online ahead of print. Lancet. 2024. PMID: 38763153 Free article.
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
Simader FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Chotai S, Bual N, Khokhar A, Gohar A, Lampadakis I, Ganesananthan S, Pathimagaraj RH, Nowbar A, Davies JR, Keeble TR, O'Kane PD, Haworth P, Routledge H, Kotecha T, Spratt JC, Williams R, Nijjer SS, Sen S, Curzen N, Sinha M, Howard JP, Cole G, Harrell FE Jr, Francis DP, Shun-Shin MJ, Al-Lamee RK; ORBITA-2 Investigators. Simader FA, et al. Among authors: howard jp. J Am Coll Cardiol. 2024 May 10:S0735-1097(24)06948-1. doi: 10.1016/j.jacc.2024.04.016. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38759906
4,705 results